Abstract:Background: The current research examines the molecular terrain of celiac disease (CD) through microRNA (miRNA) and cytokines as potential new diagnostic and therapeutic markers. Gluten-appropriate immune response is a key feature of an autoimmune clinical entity known as CD that leads to inflammation and degeneration of small intestine mucosa. However, the mechanisms responsible for this remain unclear. Methods: Quantitative reverse transcription polymerase chain reaction (RT-qPCR ) was carried out on serum samples obtained from patients with CD and control groups to unravel their pathogenesis. Assessing miR-155, miR-15b, interleukin (IL)-2, IL-7, IL-35and IL-37 levels in expression might be useful in diagnosing or treating the disorder. Results: A significant dysregulation of these molecular players in patients with CD compared with healthy controls has been evidenced by results from this study. For instance, miR-155 was up-regulated, whereas miR-15b was significantly down-regulated in CD, illustrating their roles in immune responses and inflammation-mediated processes. Besides, there was an over-expression of IL-2 and an under-expression of IL-37 in patients with CD, indicating these biomolecules' role in immuno-dysregulation and inflammatory process underlying CD. In addition, a positive correlation between IL-2 and miRNA 155 expression levels was observed in patients with CD, suggesting that they could be involved together with other cytokines, showing the interplay between immune response pathways and inflammatory cascades during CD pathogenesis. Conclusion: These molecular signature discoveries might result in new and revolutionary diagnostic modalities and molecular-targeted therapies for CD pathogenesis. When used with the scientific understanding of miRNAs and cytokines associated with CD pathophysiology, it creates a basis for personalized medicine based on the individualized molecular profile of all patients. This will undoubtedly increase the efficacy of CD treatment strategies. In brief, more research on molecular pathways' workings should be done to harness their potential in CD diagnosis and treatment.

The connection between fatty acids and inflammation in celiac disease; a deep exploring

Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation

Potential of nutraceuticals in celiac disease

Short chain fatty acids, a possible treatment option for autoimmune diseases

The Association Between Adverse Cardiovascular Outcomes in Celiac Disease and the Role of Inflammation: Retrospective Analysis Using the National Inpatient Sample

Metabolomics and lipidomics signature in celiac disease: a narrative review

Beyond the Gut: Exploring Cardiovascular Implications of Celiac Disease

Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy

Circulating MicroRNAs and Cytokines Associated with Celiac Disease

The gut microbiota and celiac disease: Pathophysiology, current perspective and new therapeutic approaches

Unraveling the causal link: fatty acids and inflammatory bowel disease

The correlation between fecal microbiota profiles and intracellular junction genes expression in young Iranian patients with celiac disease

Intestinal Microbiota and Celiac Disease: Cause, Consequence or Co-Evolution?

Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article

Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics

High Fat Diet-Wheat Gliadin Interaction and its Implication for Obesity and Celiac Disease Onset: In Vivo Studies

Impact of Nutritional Profile on Gut Microbiota Diversity in Patients with Celiac Disease

Free Fatty Acids Signature in Human Intestinal Disorders: Significant Association between Butyric Acid and Celiac Disease

Unveiling and Validating the Role of Fatty Acid Metabolism in Ulcerative Colitis

Role of gut microbiota in Crohn's disease pathogenesis: Insights from fecal microbiota transplantation in mouse model

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases